Work

Reporting of sex- and age-specific outcomes for antibody drug conjugate-induced nausea and vomiting in patients with cancer

Year: 2026
Type: article
Abstract: PURPOSE: To evaluate how often studies of antibody drug conjugate-induced nausea and vomiting (ADCINV) report demographic characteristics and demographic-specific toxicity outcomes. METHODS: We conducted a secondary analysis of 202 studies included in a systematic review of ADCINV. We summarized study country and income setting, age and sex reporting, and whether nausea and vomiting outcomes were reported by age, sex, or country/region. RESULTS: Most studies were conducted in high-income settings (144/202, 71.3%). One hundred forty-eight studies (73.3%) reported at least one age summary, although only 22 (10.9%) reported an older-adult proportion. Overall, 123 studies (60.9%) reported the percentage of female participants. No study reported nausea or vomiting outcomes stratified by age, sex, or country/region. CONCLUSION: ADC studies frequently report overall nausea and vomiting but do not provide the demographic-specific outcomes needed to evaluate differential risk. Standardized reporting by age, sex, and geographic setting is needed in future trials and real-world studies.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,690
OpenAlex ID: W7236850746
FWCI:
Cites: 24
Cited by:
Related to: 10